[Leukodystrophies--loss of myelin leads to severe disabilities].
Schenk
Maren
M
D000326:Adrenoleukodystrophy / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D000328:Adult; D001921:Brain / Q000473:pathology; D002648:Child; D003704:Dementia / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D003937:Diagnosis, Differential; D004185:Disability Evaluation; D018450:Disease Progression; D004338:Drug Combinations; D004883:Erucic Acids / Q000627:therapeutic use; D005260:Female; D020234:Gait Ataxia / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation; D020279:Hereditary Central Nervous System Demyelinating Diseases / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009128:Muscle Spasticity / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D011618:Psychotic Disorders / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D014304:Triolein / Q000627:therapeutic use
D004338:Drug Combinations; D004883:Erucic Acids; C079420:Lorenzo's oil; D014304:Triolein